Hodgkin Lymphoma
News
Drug may be curative for certain HL patients
Photo from Business Wire Five-year follow-up data from a phase 2 trial indicate that a subset of Hodgkin lymphoma (HL) patients who fail...
News
EC extends marketing authorization for brentuximab vedotin
Photo from Business Wire The European Commission (EC) has extended the current conditional marketing authorization of brentuximab vedotin (...
News
Pembrolizumab shows signs of efficacy in relapsed/refractory classical Hodgkin lymphoma
Key clinical point: Pembrolizumab is a potential treatment option for relapsed/refractory classical Hodgkin lymphoma. Major finding: The complete...
News
Adding obinutuzumab to bendamustine boosts progression-free survival in rituximab-refractory indolent non-Hodgkin lymphoma
Key clinical point: Obinutuzumab is an option when patients with indolent non-Hodgkin lymphoma relapse or don’t achieve adequate disease control...
News
Interim PET-CT can spare HL patients intensive chemo
The use of interim PET-CT scans can spare some advanced Hodgkin lymphoma (HL) patients the toxicity associated with bleomycin, according to...
Conference Coverage
Drug can address unmet need in cHL, doc says
COPENHAGEN—The PD-1 checkpoint inhibitor nivolumab can address an unmet need in patients with classical Hodgkin lymphoma (cHL) who have...
News
HIV not a contraindication for transplant in lymphoma
cultured lymphocyte Image courtesy of CDC With the advent of effective anti-retroviral therapy, patients with HIV-related lymphoma receive...
Conference Coverage
‘Impressive’ responses with nivolumab in relapsed Hodgkin lymphoma
Key clinical point:.
News
Delaying therapy for HL/NHL likely safe for mom, baby
A single-center retrospective study of 39 pregnant women diagnosed with Hodgkin lymphoma (HL) or non-Hodgkin lymphoma (NHL) during pregnancy...
Conference Coverage
Brentuximab vedotin boosted PET-negative rate in Hodgkin
Key clinical point: Brentuximab vedotin appears to eradicate residual disease after induction chemotherapy in a small study of patients with...
News
AYAs still fare worse than kids with leukemia, lymphoma
patient and her father Photo by Rhoda Baer Adolescents and young adults (AYAs) are less likely than children to survive 8 relatively common types...